Dangerous Drugs - Gleevec

Gleevec was designed to treat chronic myelogenous leukemia, or CML. The drug brings in more than a billion dollars a year in sales and has been a consistent performer for its creator, Novartis. In Europe, the drug is sold under the Glivec brand.

Recently, Gleevec has been tied to heart failure and other serious cardiac injuries. Heart failure is a serious and chronic condition which takes the life of half of those it inflicts within five years. Gleevec causes left ventricle dysfunction, leading to future heart failure.

If you or a loved one has suffered an injury, illness or death, that seems to have been someone else’s fault, call VanDerGinst Law at 1-866-843-7367 or click here for a FREE online case evaluation. The initial consultation is free of charge. If we agree to handle your injury case, we will work on a contingency fee basis, which means we get paid for our services only if, and when, there is a money recovery for you. In many cases a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. So please call right away to ensure that you do not waive your right to possible compensation.